<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; innovations</title>
	<atom:link href="http://www.newtbdrugs.org/blog/tag/innovations/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Wed, 15 May 2013 17:30:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>UPDATE Exposed:  Aeras&#8217; Upcoming Film Series on Tuberculosis</title>
		<link>http://www.newtbdrugs.org/blog/exposed-aeras-upcoming-film-series-on-tuberculosis/</link>
		<comments>http://www.newtbdrugs.org/blog/exposed-aeras-upcoming-film-series-on-tuberculosis/#comments</comments>
		<pubDate>Wed, 15 May 2013 14:59:45 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4266</guid>
		<description><![CDATA[Release of Part 1 of EXPOSED scheduled for the week of May 20.   EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals - an MDR-TB survivor, a TB doctor, a clinical trial volunteer, and a TB vaccine researcher - bringing viewers to the forefront of the race against tuberculosis.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/exposed-aeras-upcoming-film-series-on-tuberculosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tagline Spring 2013:  3 Articles on TB Research</title>
		<link>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/</link>
		<comments>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/#comments</comments>
		<pubDate>Fri, 26 Apr 2013 20:01:00 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4290</guid>
		<description><![CDATA[Treatment Action Group (TAG) recently released its Spring 2013 issue of tagline, which contains three articles about TB research that might be of interest to you-- 1) on rifapentine research and access, 2) on adaptive clinical trial designs, and 3) on pediatric drug development needs. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Database Tracks Health Technology Innovations</title>
		<link>http://www.newtbdrugs.org/blog/new-database-tracks-health-technology-innovations/</link>
		<comments>http://www.newtbdrugs.org/blog/new-database-tracks-health-technology-innovations/#comments</comments>
		<pubDate>Tue, 16 Apr 2013 22:04:06 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[market access]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[center for health market innovations]]></category>
		<category><![CDATA[chmi]]></category>
		<category><![CDATA[database]]></category>
		<category><![CDATA[global health]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[online tool]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[stop tb]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4279</guid>
		<description><![CDATA[The Center for Health Market Innovations (CHMI) has compiled profiles on over 1,200 programs and counting.  For TB innovations, the CHMI database contains 58 programs that work on TB in 33 countries. 

]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/new-database-tracks-health-technology-innovations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Get Ready for World TB Day March 24, 2013!</title>
		<link>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/</link>
		<comments>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/#comments</comments>
		<pubDate>Wed, 20 Mar 2013 21:19:29 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[march 24]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stigma]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[the union]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[wgnd]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[world tb day]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4256</guid>
		<description><![CDATA[World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bedaquiline Receives Accelerated Approval from the FDA for MDR-TB Rx</title>
		<link>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/</link>
		<comments>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/#comments</comments>
		<pubDate>Mon, 07 Jan 2013 02:34:41 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[janssen]]></category>
		<category><![CDATA[johnson and johnson]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4235</guid>
		<description><![CDATA[The FDA granted Janssen's TB drug Bedaquiline accelerated approval for treatment of MDR-TB.  A link is provided to the FDA press release and Janssen's full press release is included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>WHO Releases Global Tuberculosis Report 2012</title>
		<link>http://www.newtbdrugs.org/blog/who-releases-global-tuberculosis-report-2012/</link>
		<comments>http://www.newtbdrugs.org/blog/who-releases-global-tuberculosis-report-2012/#comments</comments>
		<pubDate>Wed, 17 Oct 2012 15:36:18 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[tb report]]></category>
		<category><![CDATA[tuberculosis]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4189</guid>
		<description><![CDATA[The WHO released the Global Tuberculosis Report 2012 today.  The main highlights and additional coverage are included.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/who-releases-global-tuberculosis-report-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Immunotherapeutic Vaccines, TB and China: Interview with Dr. Douglas Lowrie</title>
		<link>http://www.newtbdrugs.org/blog/immunotherapeutic-vaccines-tb-and-china-interview-with-dr-douglas-lowrie/</link>
		<comments>http://www.newtbdrugs.org/blog/immunotherapeutic-vaccines-tb-and-china-interview-with-dr-douglas-lowrie/#comments</comments>
		<pubDate>Thu, 11 Oct 2012 20:29:40 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB R&D Spotlight Interviews]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[animal models]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4175</guid>
		<description><![CDATA[This week we highlight an interview with Dr. Douglas Lowrie, a Senior Research Fellow at Fudan University's Shanghai Public Health Clinical Center in China.   He discusses the extent of the problem of TB in China and innovative research on enhancing TB treatment using immunotherapeutic vaccines.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/immunotherapeutic-vaccines-tb-and-china-interview-with-dr-douglas-lowrie/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  High Dose Vitamin D May Enhance TB Treatment</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-high-dose-vitamin-d-may-enhance-tb-treatment/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-high-dose-vitamin-d-may-enhance-tb-treatment/#comments</comments>
		<pubDate>Tue, 04 Sep 2012 17:46:33 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4144</guid>
		<description><![CDATA[This week we highlight a study showing promising results that providing high dose vitamin D supplements along with antibiotics could improve treatment outcomes for TB patients.  The abstract and additional news coverage are included, as well as, links to other TB R&#038;D news.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-high-dose-vitamin-d-may-enhance-tb-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur</title>
		<link>http://www.newtbdrugs.org/blog/save-the-date-2012-wgnd-annual-meeting-is-nov-14-in-kuala-lumpur/</link>
		<comments>http://www.newtbdrugs.org/blog/save-the-date-2012-wgnd-annual-meeting-is-nov-14-in-kuala-lumpur/#comments</comments>
		<pubDate>Wed, 15 Aug 2012 14:04:27 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[new tb drugs]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[the union]]></category>
		<category><![CDATA[wgnd]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4108</guid>
		<description><![CDATA[We will have our 2012 Annual Meeting in Kuala, Lumpur on <strong>Wednesday, November 14</strong> at the Impiana KLCC Hotel from 13:00 to 17:30. The meeting will be held in conjunction with the 43rd Union World Conference on Lung Health.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/save-the-date-2012-wgnd-annual-meeting-is-nov-14-in-kuala-lumpur/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update: Results from First Novel Regimen Trial Published</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-first-novel-regimen-trial-published/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-first-novel-regimen-trial-published/#comments</comments>
		<pubDate>Tue, 24 Jul 2012 19:18:00 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[EBA]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[new TB regimens]]></category>
		<category><![CDATA[phase II]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4092</guid>
		<description><![CDATA[Yesterday, efficacy data from the first novel regimen trial (NC001) were published in the Lancet.  The results found that the regimen containing PA-824, moxifloxacin, and pyrazinamide, could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments.  Link to article, press release, and related video are included.  Additional links to TB R&#038;D news are also included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-first-novel-regimen-trial-published/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
